Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05620329 · ClinicalTrials.gov registry record
UNC Pleural Fluid Registry
A clinical trial of Breast Cancer and Lung Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- 1
- Study location
NCT05620329: Recruiting study of Breast Cancer and Lung Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05620329 is a study of Breast Cancer and Lung Cancer that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05620329, a study of Breast Cancer and Lung Cancer, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 1
- Study location
Study Summary
Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.
Primary Outcome
Biological specimens and corresponding clinical data from subjects will be collected during standard of care procedures and medical record abstraction to support the creation of a pleural fluid registry.
Conditions Studied
Study Locations (1)
North Carolina
- UNC Lingeberger Comprehensive Cancer Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 2018-01-24 |
| Est. Completion | 2050-01-24 |
What NCT05620329 shows while recruiting
NCT05620329 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05620329 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05620329 about?
NCT05620329 is a clinical study titled "UNC Pleural Fluid Registry". Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for re...
What is the current status of trial NCT05620329?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2018-01-24. Estimated completion is 2050-01-24.
What conditions does trial NCT05620329 study?
This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Malignant Pleural Effusion, Lung Infection, Empyema.
Who is sponsoring clinical trial NCT05620329?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05620329 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI